Skip to main content
Passa alla visualizzazione normale.


Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C

  • Authors: Ferraro, D.; Bonura, C.; Giglio, M.; DI STEFANO, R.; Almasio, P.; DI MARCO, V.; Craxi, A.; Cacciola, I.; Squadrito, G.; Raimondo, G.
  • Publication year: 2003
  • Type: Articolo in rivista (Articolo in rivista)
  • Key words: Adult; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; RNA, Viral; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Virus Replication; Interferon-alpha; Polyethylene Glycols
  • OA Link:


Occult HBV infection in subjects with chronic hepatitis C is related to more severe disease outcome. It has been suggested that it might reduce sensitivity to antiviral treatment.